Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma

Yi Fen Wang, Jeou Yuan Chen, Shyue Yih Chang, Jen Hwey Chiu, Wing Yin Li, Pen Yuan Chu, Shyh Kuan Tai, Liang Shun Wang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We recently reported that low Nm23-H1 expression of primary oral squamous cell carcinoma (OSCC) was correlated with the occurrence of lymphatic metastasis. However, little is known about whether Nm23-H1 level of metastatic tumors in the cervical lymph nodes is reduced in comparison with primary oral cancers and its significance for patients' prognosis. By immunohistochemistry, we analyzed the Nm23-H1 expression in 52 pairs of OSCC specimens from primary oral cancers and their metastatic lymph nodes. Western blot analysis further confirmed the immunohistochemical interpretation. To verify the effects of Nm23-H1 on cell migration and invasion, we established several stable clones derived from a human OSCC cell line (SAS) by knockdown and overexpression. Wound-healing closure, transwell migration and invasion assays were performed to determine cell motility, migratory and invasive activities. Western blot analysis was carried out to evaluate cyclin A expression of OSCC cells with the altered Nm23-H1 levels following knockdown and overexpression. By immunohistochemistry, Nm23-H1 expression of metastatic lymph nodes was significantly lower than that of their primary oral cancers, supporting a role of Nm23-H1 in metastasis suppression. Negative Nm23-H1 interpretation of OSCC specimens, in either primary oral cancers or metastatic lymph nodes, indicated a poor survival outcome of patients. On the basis of in vitro studies of Nm23-H1 knockdown and overexpression, we demonstrated an inverse correlation between Nm23-H1 expression and the invasiveness of OSCC cells. Moreover, we observed the concomitant reduction in Nm23-H1 and cyclin A levels of metastatic tumors in both results of in vitro OSCC cells and ex vivo tumor specimens.

Original languageEnglish
Pages (from-to)377-386
Number of pages10
JournalInternational Journal of Cancer
Volume122
Issue number2
DOIs
Publication statusPublished - Jan 15 2008
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Lymph Nodes
Mouth Neoplasms
Neoplasms
Cyclin A
Cell Movement
Immunohistochemistry
Far-Western Blotting
Lymphatic Metastasis
Wound Healing
Clone Cells
Western Blotting
Neoplasm Metastasis
Cell Line
Survival

Keywords

  • Cyclin A
  • Metastasis
  • Nm23-H1
  • Oral squamous cell carcinoma (OSCC)

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wang, Y. F., Chen, J. Y., Chang, S. Y., Chiu, J. H., Li, W. Y., Chu, P. Y., ... Wang, L. S. (2008). Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma. International Journal of Cancer, 122(2), 377-386. https://doi.org/10.1002/ijc.23096

Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma. / Wang, Yi Fen; Chen, Jeou Yuan; Chang, Shyue Yih; Chiu, Jen Hwey; Li, Wing Yin; Chu, Pen Yuan; Tai, Shyh Kuan; Wang, Liang Shun.

In: International Journal of Cancer, Vol. 122, No. 2, 15.01.2008, p. 377-386.

Research output: Contribution to journalArticle

Wang, Yi Fen ; Chen, Jeou Yuan ; Chang, Shyue Yih ; Chiu, Jen Hwey ; Li, Wing Yin ; Chu, Pen Yuan ; Tai, Shyh Kuan ; Wang, Liang Shun. / Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma. In: International Journal of Cancer. 2008 ; Vol. 122, No. 2. pp. 377-386.
@article{90ddfc6906cc47339e94afba03416355,
title = "Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma",
abstract = "We recently reported that low Nm23-H1 expression of primary oral squamous cell carcinoma (OSCC) was correlated with the occurrence of lymphatic metastasis. However, little is known about whether Nm23-H1 level of metastatic tumors in the cervical lymph nodes is reduced in comparison with primary oral cancers and its significance for patients' prognosis. By immunohistochemistry, we analyzed the Nm23-H1 expression in 52 pairs of OSCC specimens from primary oral cancers and their metastatic lymph nodes. Western blot analysis further confirmed the immunohistochemical interpretation. To verify the effects of Nm23-H1 on cell migration and invasion, we established several stable clones derived from a human OSCC cell line (SAS) by knockdown and overexpression. Wound-healing closure, transwell migration and invasion assays were performed to determine cell motility, migratory and invasive activities. Western blot analysis was carried out to evaluate cyclin A expression of OSCC cells with the altered Nm23-H1 levels following knockdown and overexpression. By immunohistochemistry, Nm23-H1 expression of metastatic lymph nodes was significantly lower than that of their primary oral cancers, supporting a role of Nm23-H1 in metastasis suppression. Negative Nm23-H1 interpretation of OSCC specimens, in either primary oral cancers or metastatic lymph nodes, indicated a poor survival outcome of patients. On the basis of in vitro studies of Nm23-H1 knockdown and overexpression, we demonstrated an inverse correlation between Nm23-H1 expression and the invasiveness of OSCC cells. Moreover, we observed the concomitant reduction in Nm23-H1 and cyclin A levels of metastatic tumors in both results of in vitro OSCC cells and ex vivo tumor specimens.",
keywords = "Cyclin A, Metastasis, Nm23-H1, Oral squamous cell carcinoma (OSCC)",
author = "Wang, {Yi Fen} and Chen, {Jeou Yuan} and Chang, {Shyue Yih} and Chiu, {Jen Hwey} and Li, {Wing Yin} and Chu, {Pen Yuan} and Tai, {Shyh Kuan} and Wang, {Liang Shun}",
year = "2008",
month = "1",
day = "15",
doi = "10.1002/ijc.23096",
language = "English",
volume = "122",
pages = "377--386",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma

AU - Wang, Yi Fen

AU - Chen, Jeou Yuan

AU - Chang, Shyue Yih

AU - Chiu, Jen Hwey

AU - Li, Wing Yin

AU - Chu, Pen Yuan

AU - Tai, Shyh Kuan

AU - Wang, Liang Shun

PY - 2008/1/15

Y1 - 2008/1/15

N2 - We recently reported that low Nm23-H1 expression of primary oral squamous cell carcinoma (OSCC) was correlated with the occurrence of lymphatic metastasis. However, little is known about whether Nm23-H1 level of metastatic tumors in the cervical lymph nodes is reduced in comparison with primary oral cancers and its significance for patients' prognosis. By immunohistochemistry, we analyzed the Nm23-H1 expression in 52 pairs of OSCC specimens from primary oral cancers and their metastatic lymph nodes. Western blot analysis further confirmed the immunohistochemical interpretation. To verify the effects of Nm23-H1 on cell migration and invasion, we established several stable clones derived from a human OSCC cell line (SAS) by knockdown and overexpression. Wound-healing closure, transwell migration and invasion assays were performed to determine cell motility, migratory and invasive activities. Western blot analysis was carried out to evaluate cyclin A expression of OSCC cells with the altered Nm23-H1 levels following knockdown and overexpression. By immunohistochemistry, Nm23-H1 expression of metastatic lymph nodes was significantly lower than that of their primary oral cancers, supporting a role of Nm23-H1 in metastasis suppression. Negative Nm23-H1 interpretation of OSCC specimens, in either primary oral cancers or metastatic lymph nodes, indicated a poor survival outcome of patients. On the basis of in vitro studies of Nm23-H1 knockdown and overexpression, we demonstrated an inverse correlation between Nm23-H1 expression and the invasiveness of OSCC cells. Moreover, we observed the concomitant reduction in Nm23-H1 and cyclin A levels of metastatic tumors in both results of in vitro OSCC cells and ex vivo tumor specimens.

AB - We recently reported that low Nm23-H1 expression of primary oral squamous cell carcinoma (OSCC) was correlated with the occurrence of lymphatic metastasis. However, little is known about whether Nm23-H1 level of metastatic tumors in the cervical lymph nodes is reduced in comparison with primary oral cancers and its significance for patients' prognosis. By immunohistochemistry, we analyzed the Nm23-H1 expression in 52 pairs of OSCC specimens from primary oral cancers and their metastatic lymph nodes. Western blot analysis further confirmed the immunohistochemical interpretation. To verify the effects of Nm23-H1 on cell migration and invasion, we established several stable clones derived from a human OSCC cell line (SAS) by knockdown and overexpression. Wound-healing closure, transwell migration and invasion assays were performed to determine cell motility, migratory and invasive activities. Western blot analysis was carried out to evaluate cyclin A expression of OSCC cells with the altered Nm23-H1 levels following knockdown and overexpression. By immunohistochemistry, Nm23-H1 expression of metastatic lymph nodes was significantly lower than that of their primary oral cancers, supporting a role of Nm23-H1 in metastasis suppression. Negative Nm23-H1 interpretation of OSCC specimens, in either primary oral cancers or metastatic lymph nodes, indicated a poor survival outcome of patients. On the basis of in vitro studies of Nm23-H1 knockdown and overexpression, we demonstrated an inverse correlation between Nm23-H1 expression and the invasiveness of OSCC cells. Moreover, we observed the concomitant reduction in Nm23-H1 and cyclin A levels of metastatic tumors in both results of in vitro OSCC cells and ex vivo tumor specimens.

KW - Cyclin A

KW - Metastasis

KW - Nm23-H1

KW - Oral squamous cell carcinoma (OSCC)

UR - http://www.scopus.com/inward/record.url?scp=36849077813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849077813&partnerID=8YFLogxK

U2 - 10.1002/ijc.23096

DO - 10.1002/ijc.23096

M3 - Article

C2 - 17918157

AN - SCOPUS:36849077813

VL - 122

SP - 377

EP - 386

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -